Literature DB >> 2126235

Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl.

O Inoue1, S Axelsson, H Lundqvist, L Oreland, B Långström.   

Abstract

The enantiomers of methamphetamine (MAMP) and its N-propagyl derivative, deprenyl, were labelled with carbon 11, and the tissue distribution of these labelled compounds in mice was studied. Both enantiomers of 11C-MAMP rapidly entered into the brain and then disappeared according to a single exponential curve. The enantiomers of 11C-deprenyl were also rapidly distributed to various organs in the same manner. With regard to elimination, however, a stereoselective, long-term retention of radioactivity in the brain, heart and lung, due to its irreversible binding with monoamine oxidase B, was observed for L-11C-deprenyl. In reserpinized mice, the initial brain uptake of both the L and D forms of 11C-MAMP was significantly decreased. On the other hand, the brain uptake of both enantiomers of 11C-deprenyl was slightly increased by pretreatment with reserpine. A significant and non-stereoselective elevation of the lung uptake of 11C-deprenyl was also seen in reserpinized mice. In addition, both the relative tissue distribution and ratios of radioactivity in the brain compared with blood or heart at 1 and 5 min after the injection of 11C-labelled methanol in mice were not changed by reserpine. These results indicate that the transport or binding processes of these amines rather than the blood flow might be altered by reserpine. There would be an important role of the pKa values of amines in both processes. The reduction of brain uptake as well as the change in ratio between brain and heart of L-11C-MAMP in reserpinized mice 1 min after injection were reversed by treatment with amphetamine in a dose-related manner.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126235     DOI: 10.1007/bf00811438

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  27 in total

1.  Serotonin release as a possible mechanism of reserpine action.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  Science       Date:  1955-08-26       Impact factor: 47.728

2.  Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

Authors:  J S Fowler; R R MacGregor; A P Wolf; C D Arnett; S L Dewey; D Schlyer; D Christman; J Logan; M Smith; H Sachs
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

3.  Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.

Authors:  J J Freeman; F Sulser
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

4.  Saturable transport of amphetamine across the blood-brain barrier.

Authors:  W M Pardridge; J D Connor
Journal:  Experientia       Date:  1973-03-15

5.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

6.  Further studies on the interaction between desipramine and amphetamine.

Authors:  E Dolfini; M Tansella; L Valzelli; S Garattini
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

7.  A noninvasive procedure for in vivo assay of a lung amine endothelial receptor.

Authors:  J J Touya; J Rahimian; D E Grubbs; H F Corbus; L R Bennett
Journal:  J Nucl Med       Date:  1985-11       Impact factor: 10.057

8.  Studies on the mechanism of tolerance to methamphetamine.

Authors:  C J Schmidt; D R Gehlert; M A Peat; P K Sonsalla; G R Hanson; J K Wamsley; J W Gibb
Journal:  Brain Res       Date:  1985-09-23       Impact factor: 3.252

9.  Synthesis of L- and D-[methyl-11C]methionine.

Authors:  B Långström; G Antoni; P Gullberg; C Halldin; P Malmborg; K Någren; A Rimland; H Svärd
Journal:  J Nucl Med       Date:  1987-06       Impact factor: 10.057

10.  Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.

Authors:  R R MacGregor; C Halldin; J S Fowler; A P Wolf; C D Arnett; B Langström; D Alexoff
Journal:  Biochem Pharmacol       Date:  1985-09-01       Impact factor: 5.858

View more
  4 in total

1.  R-deprenyl: pharmacological spectrum of its activity.

Authors:  K Magyar; B Szende; V Jenei; T Tábi; M Pálfi; E Szöko
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

2.  PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine.

Authors:  Joanna S Fowler; Carsten Kroll; Richard Ferrieri; David Alexoff; Jean Logan; Stephen L Dewey; Wynne Schiffer; David Schlyer; Pauline Carter; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Helene Benveniste; Paul Vaska; Nora D Volkow
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

3.  Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine.

Authors:  Joanna S Fowler; Nora D Volkow; Jean Logan; David Alexoff; Frank Telang; Gene-Jack Wang; Christopher Wong; Yeming Ma; Aarti Kriplani; Kith Pradhan; David Schlyer; Millard Jayne; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog
Journal:  Neuroimage       Date:  2008-07-22       Impact factor: 6.556

4.  The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.

Authors:  David M Thomas; Dina M Francescutti-Verbeem; Donald M Kuhn
Journal:  J Neurochem       Date:  2007-12-06       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.